Nicotinell Med Peppermyntesmak

Nicotine, the active ingredient in Nicotinell Med Peppermyntesmak, is a nicotine replacement therapy presented as a buccal formulation for buccal use. It helps adults who smoke to reduce withdrawal symptoms and supports quitting smoking.

GNH USA supplies Nicotinell Med Peppermyntesmak as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell Med Peppermyntesmak is a nicotine replacement therapy used in smoking cessation.

- Smoking cessation: assists adults in quitting tobacco by alleviating nicotine withdrawal symptoms. - Nicotine dependence: provides controlled nicotine delivery to reduce cravings. - Tobacco use disorder: supports reduction of tobacco consumption as part of a cessation program.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Hiccups: transient episodes after buccal placement. - Nausea: occasional upset stomach. - Throat irritation: dryness or scratchy feeling. - Dizziness: light‑headed sensation. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Chest pain: unexpected discomfort in the chest area. - Arrhythmia: irregular heart rhythm. - Severe mouth ulceration: persistent lesions. - Hypertension exacerbation: marked increase in blood pressure. - Anaphylaxis: rapid onset of severe allergic response.

Before using Nicotinell Med Peppermyntesmak, consider the following precautions. - Assess nicotine dependence: evaluate the level of addiction to tailor therapy. - Cardiovascular disease: avoid or use with caution in recent myocardial infarction or unstable angina. - Hypertension: monitor blood pressure regularly during treatment. - Non‑smokers: product is not intended for individuals who do not use tobacco. - Keep away from children: store out of reach to prevent accidental ingestion. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Nicotinell Med Peppermyntesmak may interact with other substances as follows.

Major Interactions (Avoid): - Other nicotine‑containing products: concurrent use can lead to nicotine overdose. - Strong CYP2A6 inhibitors (e.g., methoxsalen): may increase nicotine plasma levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine‑induced tachycardia may be masked. - MAO‑inhibitors: potential for heightened blood pressure response. - Caffeine: may intensify nervous system side effects. - Antidepressants (SSRIs): monitor for increased anxiety or insomnia.